Moffitt Presentations at ASTRO 2022

Time

Abstract Type

Abstract Title

Presenter/Author

2:37 p.m.

Education

PRO 05 - Choosing Options in Rectal Cancer

Jessica Frakes

2:47 p.m.

Seminar

ARRO 01 - Applying for Jobs

Kosj Yamoah

5:42 p.m.

Education

PRO 07 - Indications for Immunotherapy with Radiation and Role of Checkpoint Blockade in Management of
Non-small Cell Lung Cancer

Bradford Perez

Time

Abstract Type

Abstract Title

Presenter/Author

8:22 a.m.

Education

PRO 08 - Intersection of Immunotherapy and SABR

Kamran Ahmed

3:26 p.m.

Special Session

PS 04 - Digital Empathy

Sarah Hoffe

3:58 p.m.

Special Session

Master Class 03 - Improving Communication: Skills and Tips for Approaching Difficult Coversations with Q&A

Jessica Frakes

4:45 p.m.

Poster Q&A

2829: Real World Rates and Predictive Factors of Pneumonitis in Advanced, Non-Resectable NSCLC Treated with Concurrent Chemoradiation and Durvalumab

Ruben Cruz-Chamorro

Time

Abstract Type

Abstract Title

Presenter/Author

10:45 a.m.

Poster Q&A

2181: Stereotactic Radiosurgery and Anti-PD-1 + CTLA-4 Therapy, Anti-PD-1 Therapy, Anti-CTLA-4 Therapy, BRAF/MEK Inhibitors, BRAF Inhibitor, or Conventional Chemotherapy for the Management of Melanoma Brain Metastases

Ammoren Dohm

10:45 a.m.

Poster Q&A

2967: Multi-Institutional Experience of MR-Guided
Stereotactic Body Radiation Therapy for Adrenal
Gland Metastases

Matthew Mills

5:00 p.m.

Poster Q&A

3180: Single Base Substitution Mutation Profiling in
Non-Matched and Matched Metastases across
Various Tumor Histologies and Anatomic Sites

Kamran Ahmed

Time

Abstract Type

Abstract Title

Presenter/Author

8:00 a.m.

Education

ST 03 - Storytelling: A Survival Kit in Time of Burnout

Peter Johnstone

12:45 p.m.

Poster Q&A

2441: Primary Tumor-Directed MRI-Guided Ablative
Radiation Therapy for Patients with Metastatic Pancreatic Adenocarcinoma

Russell Palm

12:45 p.m.

Poster Q&A

3368: Novel Hypofractionated Accelerated
Radiotherapy Dose (HARD) Utilizing Simultaneous
Integrated for Unresectable Soft Tissue Sarcomas

Matthew Mills

12:45 p.m.

Poster Q&A

3366: Neoadjuvant Simultaneous Integrated Boost
Radiotherapy Improves Outcome for Retroperitoneal Sarcoma

Casey Liveringhouse

12:50 p.m.

Oral

1061: Definitive High-Dose Radiotherapy for Primary Vulvar Cancer: The DRIVE Multicenter Cohort Study

Anupam Rishi

2:30 p.m.

Poster Q&A

2546 Clinical Outcomes of Prostate SBRT Using Non-Adaptive MR-Guided Radiotherapy (MRgRT).

Maria Sandoval

2:52 p.m.

Panel Discussion

The Dying Child or Young Adult

Ronica Nanda

4:00 p.m.

Poster Q&A

2788: Oral Mucosal Sparing in High-Dose Total Body Irradiation (TBI) prior to Stem Cell Transplantation
(SCT) for Acute Leukemia

Casey Liveringhouse

Time

Abstract Type

Abstract Title

Presenter/Author

8:30 a.m.

Scientific Session - Oral

253: Patient-Level Disease Burden as a Predictor of In-Field Failures in Patients Undergoing Bridging Radiotherapy for CD19-Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy for ecurrent/Refractory Large B-Cell Lymphomas

Nicholas Figura

10:40 a.m.

Scientific Session - Oral

263: Atezolizumab and Stereotactic Body Radiation Therapy in Metastatic, Recurrent or Persistent Cervical Cancer: Interim Results from a Non-Randomized, Open-Label Phase II Multi-Institutional Study

Kamran Ahmed

12:30 p.m.

Poster Q&A

3322: Online Adaptive MR-Guided Radiotherapy (MRgRT) in UltraCentral (UC) Lung Lesions: Cumulative Delivered Dose as Assessed with Rigid Fusion (RF) Analysis Shows Significant Improvement in Clinically Relevant Parameters

John Michael Bryant